MODULE 4-3 CASE STUDY: ENDOCRINE AND NEURAL DRUG TREATMENT. Michelle L. Groover Southern New Hampshire University IHP 310: Pathophysiology and Pharmacology Professor Brown July 21, 2023. Module 4-3 Case Study: Endocrine and Neural Drug Treatment Scenario: Bill, age 70, came to the examination accompanied by his wife.
IHP310 4-3 Case Study Endocrine and Neural Drug Treatment
Module Four Case Study. Heather A. Southern New Hampshire University. IHP 310 - Pathophysiology & Pharmacology. Module Four Case Study. Rochelle Davis, MSN-ADM, RN, MBA. Due Date 3/27/ GRADE 29/ IHP 310 Module Four Case Study. Prompt: Consider the following scenario: Bill, age 70, came to the examination accompanied by his wife. Bill was tall ...
4-3 Case Study Endocrine-Neural Drug Treatment
4-3 Case Study: Endocrine & Neural Drug Treatment Southern New Hampshire University IHP-310 Pathophysiology & Pharmacology Professor Davis Lakesha Wright 7/21/2023. This case study was an interesting one because the patient is 70 years old, and he has a hard time remembering things that he has done for years.
4-3 Case Study Endocrine & Neural Drug Treatment.docx
ENDOCRINE & NEURAL DRUG TREATMENT 4 Cholinesterase Inhibitor Drugs: Some generic drugs that inhibit cholinesterase include donepezil (Aricept), galantamine (Razadyne), and rivastigmine (Exelon). These medications are the most successful for alleviating and/or controlling symptoms from worsening as they work to increase levels of acetylcholine, a neurotransmitter involved in memory and thinking ...
IHP 310 4-3 Case Study.docx
4-3 Case Study: Endocrine and Neural Drug Treatment Alexandra Pittman Southern New Hampshire University IHP 310: Pathophysiology & Pharmacology Professor Rebecca Gayheart May 30, 2021 After reviewing the case study, I found that there were inaccuracies with the patient's information and treatment.
IHP310_4-3 Case Study Endocrine and Neural Drug Treatment ...
IHP310_4-3 Case Study Endocrine and Neural Drug Treatment_2022-2023_SNHU. School Southern New Hampshire University - Manchester, NH; Course Title IHP 310 - Pathophysiology and Pharmacology Concepts; ... The e case e that e has e been e examined e involves e Bill, e a e 70-year-old e man e who e has e been e.
4-3 Case Study Endocrine and Neural Drug Treatment Menard.docx
4-3 CASE STUDY After reading over the case study, there seems to be some inaccurate information and data with the given patient information, analysis, and treatment. The doctor had determined the patient Bill has Alzheimer's. "Alzheimer's disease is a progressive disorder that causes brain cells to waste away and die. Alzheimer's disease is the most common cause of dementia - a ...
4-3 Case Study
4-3 Case Study: Endocrine and Neural Drug Treatment. Taylor Henderson Southern New Hampshire University IHP310: Pathophysiology and Pharmacology Rebecca Gayheart, MSN, APRN, FNP-C, CNL September 19, 2023. 2. Incorrect Medication/Drug Classification/Treatment In this case study, Bill, a 70-year old male, was just recently diagnosed with ...
IHP-310 4-3 Case Study Endocrine and Neural Drug Treatment.docx
In this case study involving Bill, age 70, who had just been diagnosed with Alzheimer's disease, we can see that an incorrect drug classification was used in his treatment plan. Anticholinergic drugs inhibit the action of acetylcholine at cholinergic receptors and work to prolong the action of dopamine in the brain (Turley, 2021). Anticholinergic drugs are used in the treatment of Parkinson ...
IHP 310
Endocrine and Neural Disorders and Drug Treatment. ... 4-2 Discussion: E ndocrine and Neural Disorders . 4-3 Case Study: End ocrine and Neural Drug Treatment . 5 . Reproductive and Urin ary Disorders and Drug ... Ear, Eye, N ose, Throat, and Gastrointestinal Dis orders and Drug Treatment. Pathophysiology: A Prac tical Approach, Chapters 9 an ...
Chapter 9 Endocrine System
Overview of the Endocrine System. This chapter will discuss medications that affect three major endocrine glands and their hormones: the adrenal glands, the pancreas, and the thyroid. See Table 9.2 for a list of hormones associated with each of these glands and their effects. [ 3]
Ihp 310 Module four case study.docx
2 4-3 Case Study: Endocrine and Neural Drug Therapy Incorrect Medication/Treatment Bill age 70 came into the physician's office with symptoms that would show he was having loss of memory and was unable to do tasks such as balancing his checkbook. The physician concluded that Bill was suffering from Alzheimer's disease, and I agree with that " Alzheimer's disease is an irreversible ...
Endocrine and Neural Disorders and Drug Treatment
Endocrine and Neural Disorders and Drug Treatment. School Southern New Hampshire University - Manchester, NH; ... Identify key v ocabu lary, disord ers, and d rugs of endocrine and neura l . disorders . b. ... 3. Complete the case s tudy on endo crine a nd neural dr ug tr eatment. 4.
IHP310 Pathophysiology Pharmacology 4-3 Case Study.docx
4-3 case study: endocrine and neural drug treatment 3 There are two drug classifications that can be used: NMDA receptor antagonist drugs and cholinesterase inhibitors. "Cholinesterase inhibitor drugs inhibit (prevent) cholinesterase from breaking down the already inadequate amount of acetylcholine that is a characteristic of Alzheimer's ...
4-3 Case Study- Endocrine and Neural Drug Treatment.docx
A Cholinesterase inhibitor would be the best type of drug to use. They are prescribed in order to "treat symptoms related to memory, thinking, language, judgment and other thought processes ("Medications for Memory", 2020)." They can help delay or slow down the symptoms of AD. Memantine, a NMDA Antagonists, has also been effective as it helps improve mental function and with information ...
COMMENTS
MODULE 4-3 CASE STUDY: ENDOCRINE AND NEURAL DRUG TREATMENT. Michelle L. Groover Southern New Hampshire University IHP 310: Pathophysiology and Pharmacology Professor Brown July 21, 2023. Module 4-3 Case Study: Endocrine and Neural Drug Treatment Scenario: Bill, age 70, came to the examination accompanied by his wife.
Module Four Case Study. Heather A. Southern New Hampshire University. IHP 310 - Pathophysiology & Pharmacology. Module Four Case Study. Rochelle Davis, MSN-ADM, RN, MBA. Due Date 3/27/ GRADE 29/ IHP 310 Module Four Case Study. Prompt: Consider the following scenario: Bill, age 70, came to the examination accompanied by his wife. Bill was tall ...
4-3 Case Study: Endocrine & Neural Drug Treatment Southern New Hampshire University IHP-310 Pathophysiology & Pharmacology Professor Davis Lakesha Wright 7/21/2023. This case study was an interesting one because the patient is 70 years old, and he has a hard time remembering things that he has done for years.
ENDOCRINE & NEURAL DRUG TREATMENT 4 Cholinesterase Inhibitor Drugs: Some generic drugs that inhibit cholinesterase include donepezil (Aricept), galantamine (Razadyne), and rivastigmine (Exelon). These medications are the most successful for alleviating and/or controlling symptoms from worsening as they work to increase levels of acetylcholine, a neurotransmitter involved in memory and thinking ...
4-3 Case Study: Endocrine and Neural Drug Treatment Alexandra Pittman Southern New Hampshire University IHP 310: Pathophysiology & Pharmacology Professor Rebecca Gayheart May 30, 2021 After reviewing the case study, I found that there were inaccuracies with the patient's information and treatment.
IHP310_4-3 Case Study Endocrine and Neural Drug Treatment_2022-2023_SNHU. School Southern New Hampshire University - Manchester, NH; Course Title IHP 310 - Pathophysiology and Pharmacology Concepts; ... The e case e that e has e been e examined e involves e Bill, e a e 70-year-old e man e who e has e been e.
4-3 CASE STUDY After reading over the case study, there seems to be some inaccurate information and data with the given patient information, analysis, and treatment. The doctor had determined the patient Bill has Alzheimer's. "Alzheimer's disease is a progressive disorder that causes brain cells to waste away and die. Alzheimer's disease is the most common cause of dementia - a ...
4-3 Case Study: Endocrine and Neural Drug Treatment. Taylor Henderson Southern New Hampshire University IHP310: Pathophysiology and Pharmacology Rebecca Gayheart, MSN, APRN, FNP-C, CNL September 19, 2023. 2. Incorrect Medication/Drug Classification/Treatment In this case study, Bill, a 70-year old male, was just recently diagnosed with ...
In this case study involving Bill, age 70, who had just been diagnosed with Alzheimer's disease, we can see that an incorrect drug classification was used in his treatment plan. Anticholinergic drugs inhibit the action of acetylcholine at cholinergic receptors and work to prolong the action of dopamine in the brain (Turley, 2021). Anticholinergic drugs are used in the treatment of Parkinson ...
Endocrine and Neural Disorders and Drug Treatment. ... 4-2 Discussion: E ndocrine and Neural Disorders . 4-3 Case Study: End ocrine and Neural Drug Treatment . 5 . Reproductive and Urin ary Disorders and Drug ... Ear, Eye, N ose, Throat, and Gastrointestinal Dis orders and Drug Treatment. Pathophysiology: A Prac tical Approach, Chapters 9 an ...
Overview of the Endocrine System. This chapter will discuss medications that affect three major endocrine glands and their hormones: the adrenal glands, the pancreas, and the thyroid. See Table 9.2 for a list of hormones associated with each of these glands and their effects. [ 3]
2 4-3 Case Study: Endocrine and Neural Drug Therapy Incorrect Medication/Treatment Bill age 70 came into the physician's office with symptoms that would show he was having loss of memory and was unable to do tasks such as balancing his checkbook. The physician concluded that Bill was suffering from Alzheimer's disease, and I agree with that " Alzheimer's disease is an irreversible ...
Endocrine and Neural Disorders and Drug Treatment. School Southern New Hampshire University - Manchester, NH; ... Identify key v ocabu lary, disord ers, and d rugs of endocrine and neura l . disorders . b. ... 3. Complete the case s tudy on endo crine a nd neural dr ug tr eatment. 4.
4-3 case study: endocrine and neural drug treatment 3 There are two drug classifications that can be used: NMDA receptor antagonist drugs and cholinesterase inhibitors. "Cholinesterase inhibitor drugs inhibit (prevent) cholinesterase from breaking down the already inadequate amount of acetylcholine that is a characteristic of Alzheimer's ...
A Cholinesterase inhibitor would be the best type of drug to use. They are prescribed in order to "treat symptoms related to memory, thinking, language, judgment and other thought processes ("Medications for Memory", 2020)." They can help delay or slow down the symptoms of AD. Memantine, a NMDA Antagonists, has also been effective as it helps improve mental function and with information ...